{1 (chlorpheniramine maleate 0.2 MG/ML / dextromethorphan hydrobromide 1.5 MG/ML Oral Susp... — RxCUI 2743069
RxNorm drug concept · Generic pack
RxCUI 2743069
Generic pack · GPCK
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2743069
Official name{1 (chlorpheniramine maleate 0.2 MG/ML / dextromethorphan hydrobromide 1.5 MG/ML Oral Suspension) / 1 (dextromethorphan hydrobromide 1 MG/ML / guaifenesin 20 MG/ML Oral Suspension) } Pack
Concept typeGeneric pack (GPCK)
RxNorm statusCurrent RxNorm concept
Also known as1 daytime (dextromethorphan HBr 5 MG / guaifenesin 100 MG per 5 ML Oral Suspension) / 1 nighttime (chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 15 MG per 10 ML Oral Suspension) Pack; 1 daytime (dextromethorphan HBr 5 MG / guaiFENesin 100 MG in 5 mL Oral Suspension) / 1 nighttime (chlorpheniramine maleate 2 MG / dextromethorphan HBr 15 MG in 10 mL Oral Suspension) Pack
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Dextromethorphan: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It won't necessarily silence your cough entirely, but it does temporarily suppress the cough reflex and reduce how intense and frequent your cough is. It can also help reduce that...
- What exactly does dextromethorphan do — will it stop my cough completely?
- It depends on your child's age and the specific product. Most dextromethorphan products should not be given to children under 4 years old without a doctor's guidance. Some products...
- This is a really important question. If your antidepressant is an MAOI (monoamine oxidase inhibitor), you absolutely cannot take dextromethorphan — not while you're on it, and not...
🕸️ Concept Web — How {1 (chlorpheniramine maleate 0.2 MG/ML / dextrom... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
{1 (chlorpheniramine maleate 0.2 MG/ML / dextromethorphan hydrobromide 1.5 MG/ML Oral Suspension) / 1 (dextromethorphan hydrobromide 1 MG/ML / guaifenesin 20 MG/ML Oral Suspension) } Pack
RxCUI 2743069 Generic pack · GPCK
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 7
The active substance itself — no strength, form, or brand attached yet.
-
Chlorpheniramine
2400IN -
Dextromethorphan
3289IN -
Guaifenesin
5032IN -
Chlorpheniramine / dextromethorphan
214390MIN -
Dextromethorphan / guaifenesin
214488MIN -
Chlorpheniramine maleate
142429PIN -
Dextromethorphan hydrobromide
102490PIN
-
Chlorpheniramine
-
Dose forms 15
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Chlorpheniramine / dextromethorphan Oral Suspension
2743066SCDF -
Dextromethorphan / guaifenesin Oral Suspension
371765SCDF -
Chlorpheniramine maleate / dextromethorphan hydrobromide Oral Suspension
2743067SCDFP -
Dextromethorphan hydrobromide / guaifenesin Oral Suspension
2645981SCDFP -
Chlorpheniramine / dextromethorphan Oral Liquid Product
1154179SCDG -
Chlorpheniramine / dextromethorphan Oral Product
1154180SCDG -
Dextromethorphan / guaifenesin Oral Liquid Product
1155190SCDG -
Dextromethorphan / guaifenesin Oral Product
1155191SCDG - +7 more in this family
-
Chlorpheniramine / dextromethorphan Oral Suspension
-
Clinical & branded drugs 6
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Chlorpheniramine maleate 0.2 MG/ML / dextromethorphan hydrobromide 1.5 MG/ML Oral Suspension
2743068SCD -
Dextromethorphan hydrobromide 1 MG/ML / guaifenesin 20 MG/ML Oral Suspension
2692303SCD -
Chlorpheniramine maleate 0.2 MG/ML
1038875SCDC -
Dextromethorphan hydrobromide 1 MG/ML
1020137SCDC -
Dextromethorphan hydrobromide 1.5 MG/ML
1090505SCDC -
Guaifenesin 20 MG/ML
316011SCDC
-
Chlorpheniramine maleate 0.2 MG/ML / dextromethorphan hydrobromide 1.5 MG/ML Oral Suspension
Showing up to 8 concepts per family — 21 of 28 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Chlorpheniramine maleate 0.2 MG/ML / dextromethorphan hydrobromide 1.5 MG/ML Oral Suspension
SCD · 2743068 -
Dextromethorphan hydrobromide 1 MG/ML / guaifenesin 20 MG/ML Oral Suspension
SCD · 2692303 -
Chlorpheniramine maleate 0.2 MG/ML
SCDC · 1038875 -
Dextromethorphan hydrobromide 1 MG/ML
SCDC · 1020137 -
Dextromethorphan hydrobromide 1.5 MG/ML
SCDC · 1090505 -
Guaifenesin 20 MG/ML
SCDC · 316011 -
Chlorpheniramine / dextromethorphan Oral Suspension
SCDF · 2743066 -
Dextromethorphan / guaifenesin Oral Suspension
SCDF · 371765 -
Chlorpheniramine maleate / dextromethorphan hydrobromide Oral Suspension
SCDFP · 2743067 -
Dextromethorphan hydrobromide / guaifenesin Oral Suspension
SCDFP · 2645981
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 2743069 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 69676-0110-09 | 2 BOTTLE, PLASTIC in 1 BOX (69676-0110-9) / 1 KIT in 1 BOTT... | Kids Daytime Cough and Nighttime Cough combo pack | Genexa Inc. | 2026-03-20 |
Observed labelers:
Genexa Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.